Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Metlife ( (MET) ) has issued an update.
On December 1, 2025, MetLife, Inc. announced the completion of a $10 billion variable annuity risk transfer transaction with Talcott Resolution Life Insurance Company. This transaction is part of MetLife’s strategy to reduce portfolio risk and accelerate the run-off of its legacy business blocks, resulting in expected annual adjusted earnings loss of approximately $100 million, partially offset by $45 million in hedge cost savings. MetLife Investment Management will manage around $6 billion of assets under investment management agreements with Talcott.
The most recent analyst rating on (MET) stock is a Hold with a $86.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.
Spark’s Take on MET Stock
According to Spark, TipRanks’ AI Analyst, MET is a Neutral.
MetLife’s overall stock score reflects a stable financial foundation and strong earnings growth, particularly in the PRT and Asia segments. While technical indicators are mixed and valuation is fair, the company’s efficient expense management and strategic initiatives support a positive outlook. However, challenges in revenue growth and profitability need to be addressed to sustain long-term performance.
To see Spark’s full report on MET stock, click here.
More about Metlife
MetLife, Inc. is a leading global financial services company that provides insurance, annuities, employee benefits, and asset management services. Founded in 1868, the company operates in over 40 markets worldwide, holding significant positions in the United States, Asia, Latin America, Europe, and the Middle East.
Average Trading Volume: 3,506,524
Technical Sentiment Signal: Buy
Current Market Cap: $50.44B
See more insights into MET stock on TipRanks’ Stock Analysis page.

